Bristol-Myers Squibb (BMY) Q3 2021 Earnings Call Transcript

·51-min read
Bristol-Myers Squibb (BMY) Q3 2021 Earnings Call Transcript

At this time, I would like to turn the conference over to Mr. Tim Power, vice president investor relations. Joining me this morning with prepared remarks are Giovanni Caforio, our board chair and chief executive officer; and David Elkins, our chief financial officer. Also with me for today's call are Chris Boerner, our chief commercialization officer; and Samit Hirawat, our chief medical officer and head of global drug development.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting